Cite
MLA Citation
Pradeep J. Nathan et al.. “A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease.” Alzheimer's & dementia, vol. 8, no. 1, 2022, p. n/a. http://access.bl.uk/ark:/81055/vdc_100173234029.0x000004